Good health and well-being

Information technology can significantly advance the delivery of healthcare, addressing problems from the high risk of maternal death across Africa to the treatment of rare diseases. Our health partnerships directly support organizations working to “ensure healthy lives and promote well-being for all at all ages”.

SDG 3 - Good health and well being

Explore our contributions to SDG 3.


This partnership is driven by the Elsevier Foundation

Amref Health Africa is the largest African driven NGO committed to improving health and health care in Africa. AMREF Health Africa’s JIBU program is working to scale their mobile nursing education pilot into a comprehensive program to provide targeted mLearning or mobile nursing education in Eastern Africa.

AMREF/Innovate for Life fund

This partnership is driven by the Elsevier Foundation

Supporting African entrepreneurs to develop home-grown innovations for health: this is the goal of Innovate for Life, an initiative launched by Amref Flying Doctors. We are proud to support Amref’s goal to help early-stage entrepreneurs developing novel technological solutions. The Fund aims to bridge the gap between African entrepreneurs and international investors by offering deep subject matter knowledge, strong networks and access to funding.

Doctors without Borders/Médecins Sans Frontières and Epicentre

This partnership is driven by the Elsevier Foundation

Doctors Without Borders/Médecins Sans Frontières (MSF) is a leading international organization delivering emergency medical aid to people affected by conflict, epidemics, disasters, or exclusion from health care. We collaborate with Epicentre, MSF’s research and training partner, to support their Niger Research Center with in kind help and a $300,000 grant over a period of 3 years, with a goal of building field-based research capacity to deliver better medical care worldwide.


Congenital Hyperinsulinism (CHI) is an ultra-rare disease where new-borns have a permanently excessive level of insulin in the blood, which can lead to brain injury or death if not caught quickly. To help battle CHI, Elsevier is working with Findacure, a UK-based charity whose mission is to build the rare disease community to drive research and develop treatments, by analyzing the disease’s biological pathways and structure, as well as by looking at already published literature. Findacure is setting up a social impact bond for rare disease drug repurposing to provide a platform to fund promising projects identified by patient groups, clinicians and researchers.

Sansum Diabetes Research Institute/Latino Diabetes

Sansum Diabetes Research Institute

This partnership is driven by the Elsevier Foundation

Starting 2020, the Elsevier Foundation will be supporting a Sansum Diabetes Research Institute program aiming at creating the first Hispanic/Latino Citizen Scientists to train wearable tech and clinical research to reduce health literacy barriers amongst Latino adults with or at risk of type 2 diabetes.